Trial Profile
A phase I/II pharmacokinetic and safety study of Fuzeon [enfuvirtide] in combination with an optimized background in HIVinfected children and adolescents
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 31 Mar 2006
Price :
$35
*
At a glance
- Drugs Enfuvirtide (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Trimeris
- 31 Mar 2006 New trial record.